Steven Sherman - Mar 15, 2022 Form 4 Insider Report for EKSO BIONICS HOLDINGS, INC. (EKSO)

Role
CEO & Chairman, Director
Signature
/s/ John F. Glenn, as Attorney-in-Fact
Stock symbol
EKSO
Transactions as of
Mar 15, 2022
Transactions value $
-$15,508
Form type
4
Date filed
3/17/2022, 05:19 PM
Previous filing
May 17, 2023
Next filing
Mar 22, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EKSO Common Stock Sale -$15.5K -5.97K -0.97% $2.60* 610K Mar 15, 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares sold by the Reporting Person on March 15, 2022 to cover tax withholding obligations incurred upon the vesting and settlement of the first installment of a restricted stock unit award originally reported by the Reporting Person in Form 4 filed with the Commission on March 10, 2022.
F2 The sale price represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $2.5980 to $2.60, inclusive. The Company can provide the full information regarding the number of shares sold at each separate price upon further request.